Skip to content
Intravacc
IntravaccIntravacc
  • Publications
    • Scientific Publications
    • Vaccsheets
    • Annual report
  • Events
  • News
  • Career
  • Partnering
  • About us
    • Company profile
    • Board of Directors
    • Management Team
    • Supervisory Board
    • Scientific advisory board
  • Services
    • Vaccine development
      • Process development
        • Upstream processing
        • Downstream processing
        • Formulation
      • Vaccine strain design
      • GMP
    • Assays
      • Analytical method development
  • Platforms
    • Cell based platform
    • OMV Platform
    • Conjugate vaccines
  • Products
  • 3R Research
Contact
Search:
  • Publications
    • Scientific Publications
    • Vaccsheets
    • Annual report
  • Events
  • News
  • Career
  • Partnering
  • About us
    • Company profile
    • Board of Directors
    • Management Team
    • Supervisory Board
    • Scientific advisory board
  • Services
    • Vaccine development
      • Process development
        • Upstream processing
        • Downstream processing
        • Formulation
      • Vaccine strain design
      • GMP
    • Assays
      • Analytical method development
  • Platforms
    • Cell based platform
    • OMV Platform
    • Conjugate vaccines
  • Products
  • 3R Research

Formulation and adjuvants

You are here:
  1. Home
  2. Category "Formulation and adjuvants"

Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteria

Formulation and adjuvantsBy Mirjam Hartman01/07/2022

Activation of Canine, Mouse and Human TLR2 and TLR4 by Inactivated Leptospira Vaccine Strains

Formulation and adjuvantsBy Mirjam Hartman17/06/2022

Aluminum Hydroxide And Aluminum Phosphate Adjuvants Elicit A Different Innate Immune Response

Formulation and adjuvantsBy Mirjam Hartman17/06/2022

The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella

Formulation and adjuvantsBy Mirjam Hartman22/03/2022

Nanoflow LC-MS Method Allowing In-Depth Characterization of Natural Heterogeneity of Complex Bacterial Lipopolysaccharides

Formulation and adjuvantsBy Mirjam Hartman28/01/2022

Developments in the formulation and delivery of spray dried vaccines

Formulation and adjuvantsBy Mirjam Hartman02/08/2021

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8 + T Cell Epitopes

Formulation and adjuvantsBy Mirjam Hartman12/10/2020

Vaccine antigens modulate the innate response of monocytes to Al(OH)3

Formulation and adjuvantsBy Mirjam Hartman12/10/2020

Universal Applicator for Digitally-Controlled Pressing Force and Impact Velocity Insertion of Microneedles into Skin

Formulation and adjuvantsBy Mirjam Hartman12/10/2020

The effect of formulation on spray dried Sabin inactivated polio vaccine

Formulation and adjuvantsBy Mirjam Hartman12/10/2020
→12345→

Copyright © 2018 Intravacc - Privacy & Disclaimer

ISO Certifications: ISO 14001

Go to Top

We gebruiken cookies om u de beste ervaring op onze website te bieden. U kunt meer te weten komen over welke cookies we gebruiken of ze uitschakelen in instellingen .

Intravacc
Privacy overzicht

Deze website maakt gebruik van cookies zodat we u de best mogelijke gebruikerservaring kunnen bieden. Cookie-informatie wordt opgeslagen in uw browser en voert functies uit zoals u herkennen wanneer u terugkeert naar onze website en ons team helpen begrijpen welke delen van de website u het meest interessant en nuttig vindt.

Strikt noodzakelijke cookies

Strikt noodzakelijke cookies moeten te allen tijde zijn ingeschakeld, zodat we uw voorkeuren voor cookie-instellingen kunnen opslaan.

Als u deze cookie uitschakelt, kunnen we uw voorkeuren niet opslaan. Dit betekent dat u elke keer dat u deze website bezoekt, cookies opnieuw moet in- of uitschakelen.